Metraipolis › archive › dc_045e197ce32d

Stability modification of therapeutic aptamers: from biostability bottlenecks to nuclease-resistant construct design — Europe PMC PMID:42131729

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42131729
DOI
10.1039/d6cb00062b
License (as archived)
solo-consultazione
Archived
2026-11-02T15:32:28.741Z
SHA-256 of the archived text
b332a4aa02b40aa665f92eef3ea1655be0919e06f8db36e6c3438a9df5e2fda5
Stable URL of this page
https://metraipolis.com/documento/dc_045e197ce32d

How to cite

Stability modification of therapeutic aptamers: from biostability bottlenecks to nuclease-resistant construct design — Europe PMC PMID:42131729 — Europe PMC (en), https://europepmc.org/article/MED/42131729 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_045e197ce32d (Metraipolis archive dc_045e197ce32d, sha256 b332a4aa02b40aa665f92eef3ea1655be0919e06f8db36e6c3438a9df5e2fda5)
BibTeX
@misc{dc045e197ce32d,
  title = {Stability modification of therapeutic aptamers: from biostability bottlenecks to nuclease-resistant construct design — Europe PMC PMID:42131729},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42131729},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_045e197ce32d; sha256 b332a4aa02b40aa665f92eef3ea1655be0919e06f8db36e6c3438a9df5e2fda5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42131729. Agents can read the archived copy with the MCP tool read_document.